These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 24122656)

  • 1. Possible participation of acidic pH in bone resorption in middle ear cholesteatoma.
    Nguyen KH; Suzuki H; Ohbuchi T; Wakasugi T; Koizumi H; Hashida K; Baba R; Morimoto H; Doi Y
    Laryngoscope; 2014 Jan; 124(1):245-50. PubMed ID: 24122656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased permeability of the epithelium of middle ear cholesteatoma.
    Koizumi H; Suzuki H; Ohbuchi T; Kitamura T; Hashida K; Nakamura M
    Clin Otolaryngol; 2015 Apr; 40(2):106-14. PubMed ID: 25319490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of PTHrP and RANKL in acquired middle ear cholesteatoma epithelium.
    Xie S; Pan Z; Yin T; Ren J; Liu W
    Acta Otolaryngol; 2020 May; 140(5):351-355. PubMed ID: 32108533
    [No Abstract]   [Full Text] [Related]  

  • 4. HB-EGF expression as a potential biomarker of acquired middle ear cholesteatoma.
    Xie S; Wang X; Ren H; Liu X; Ren J; Liu W
    Acta Otolaryngol; 2017 Aug; 137(8):797-802. PubMed ID: 28498080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expressions of caspase-14 in human middle ear cholesteatoma.
    Jung MH; Lee JH; Cho JG; Jung HH; Hwang SJ; Chae SW
    Laryngoscope; 2008 Jun; 118(6):1047-50. PubMed ID: 18520823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expressions of TRPVs in the cholesteatoma epithelium.
    Do BH; Koizumi H; Ohbuchi T; Kawaguchi R; Suzuki H
    Acta Otolaryngol; 2017 Oct; 137(10):1039-1045. PubMed ID: 28599589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of N-acetyl-beta-d-hexosaminidase in cholesteatoma tissue.
    Olszewska E; Olszewski S; Borzym-Kluczyk M; Zwierz K
    Acta Biochim Pol; 2007; 54(2):365-70. PubMed ID: 17502924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of bone resorption in the etiopathogenesis of acquired middle ear cholesteatoma.
    Xie S; Wang X; Ren J; Liu W
    Eur Arch Otorhinolaryngol; 2017 May; 274(5):2071-2078. PubMed ID: 27981350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A study on expression of tumor necrosis factor alpha in middle ear cholesteatoma and its effect on bone destruction].
    Li Z; Li X; Liu G
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Feb; 15(2):66-7. PubMed ID: 12541866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Carcinoembryonic antigen in chronic otitis media with cholesteatoma].
    Sanković-Babić S; Sofronić-Milosavljević Lj
    Srp Arh Celok Lek; 2000; 128(3-4):80-3. PubMed ID: 10932614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hexosoaminidase gene expression in cholesteatoma in adults].
    Rutkowska J; Olszewska E; Waniewska E; Czechowska S; Kowalczuk O; Borawska M; Zukowska M; Markiewicz R; Rogowski M
    Otolaryngol Pol; 2009; 63(6):490-5. PubMed ID: 20198983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of peroxidase proliferator-activated receptor gamma in cholesteatoma.
    Hwang SJ; Kang HJ; Song JJ; Kang JS; Woo JS; Chae SW; Lee HM
    Laryngoscope; 2006 Jan; 116(1):58-61. PubMed ID: 16481810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nature of the epithelium in acquired cholesteatoma: Part 3--Cytokeratin patterns in aural epithelial and cholesteatoma cells grown in cell culture.
    Lee RJ; Sidey C; Narula AA; James RF
    Clin Otolaryngol Allied Sci; 1994 Dec; 19(6):516-20. PubMed ID: 7534665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of a cathelicidin antimicrobial peptide is augmented in cholesteatoma.
    Jung HH; Chae SW; Jung SK; Kim ST; Lee HM; Hwang SJ
    Laryngoscope; 2003 Mar; 113(3):432-5. PubMed ID: 12616192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression patterns of p27Kip1 and Ki-67 in cholesteatoma epithelium.
    Chae SW; Song JJ; Suh HK; Jung HH; Lim HH; Hwang SJ
    Laryngoscope; 2000 Nov; 110(11):1898-901. PubMed ID: 11081606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The roles of interleukin-1 alpha, tumor necrosis factor-alpha and parathyroid hormone-related protein in bone resorption of cholesteatoma otitis].
    Kinoshita K
    Nihon Jibiinkoka Gakkai Kaiho; 1994 Aug; 97(8):1472-80. PubMed ID: 7931803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear.
    Schilling V; Negri B; Bujía J; Schulz P; Kastenbauer E
    Am J Otol; 1992 Jul; 13(4):350-5. PubMed ID: 1384343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of matrix-degrading cysteine proteinase cathepsin K in cholesteatoma.
    Hansen T; Unger RE; Gaumann A; Hundorf I; Maurer J; Kirkpatrick CJ; Kriegsmann J
    Mod Pathol; 2001 Dec; 14(12):1226-31. PubMed ID: 11743044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The expression of Ras protein in human middle ear cholesteatoma].
    Xu Y; Jin K; Dong W
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Apr; 34(2):74-6. PubMed ID: 12764851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of ErbB-2 protein in human middle ear cholesteatomas.
    Sakamoto T; Kondo K; Yamasoba T; Suzuki M; Sugasawa M; Kaga K
    Laryngoscope; 2004 Nov; 114(11):1988-91. PubMed ID: 15510028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.